The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

On his 59th birthday, Shah Rukh Khan announced that he had finally quit smoking.For someone who has been a regular smoker for ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... or long-acting beta agonist (LABA) drugs.

In 2023, Chiesi group's revenue exceeded 3 billion euros ($3.24 billion), representing a 10 percent increase from 2022, with ...

For families already under immense stress, the added burden of sourcing medications outside, coupled with the financial ...

"The hospital has to offer a hospital-at-home program, the patient has to qualify medically by not needing the ICU or a high-tech admission, and the patient needs to have a suitable home with running ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...

The Company's proprietary product pipeline includes treatments for CNS disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease ("COPD") and allergic ..

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for COPD. This article covers topics such as side effects, dosage ...

Health care providers treating people with COPD also need to focus on the person's socioeconomic factors, along with ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...